These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Clinical and hemodynamic effects of medium-term treatment with muzolimine in subjects with essential arterial hypertension]. Licata G; Scaglione R; Parrinello G; Rini GB; Asta N G Ital Cardiol; 1986 Jul; 16(7):583-5. PubMed ID: 3781147 [TBL] [Abstract][Full Text] [Related]
24. Hemodynamic measurements as aids to choosing drug treatment of essential hypertension. Chen HC Clin Ther; 1985; 7(2):176-80. PubMed ID: 3986862 [TBL] [Abstract][Full Text] [Related]
25. [Multicenter study with 3 different doses of ketanserin in essential arterial hypertension]. Cruz J; Moscovici H; Silva AN; Finkielman S; Milei J; Geyer G; Feltkamp H; Stumpe KO; Berges LC Arq Bras Cardiol; 1985 Oct; 45(4):299-304. PubMed ID: 2940997 [No Abstract] [Full Text] [Related]
26. [New approaches to the treatment of stable and malignant arterial hypertension]. Bykov AV; Leshchinskiĭ PM; Runikhin AIu; Iakobashvili MA; Nikol'skaia VV Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(1):93-4. PubMed ID: 2871845 [No Abstract] [Full Text] [Related]
28. [Medical treatment of arterial hypertension: hemodynamic study]. Safar M; Milliez P Rev Eur Etud Clin Biol; 1971 Apr; 16(4):334-42. PubMed ID: 5564545 [No Abstract] [Full Text] [Related]
29. [Clinical and hemodynamic study of a new antihypertensive agent]. Palmero HA; Caeiro AE; Lussi H; Massari P; Amuchastegui S Prensa Med Argent; 1968 Aug; 55(25):1212-6. PubMed ID: 4885121 [No Abstract] [Full Text] [Related]
30. [Long-term treatment of hypertension with a selective beta l-blocker without sympathomimetic activity. I. Antihypertensive and hemodynamic effects]. Sirakova V; Penkov N; Kaponov Kh Vutr Boles; 1988; 27(6):21-5. PubMed ID: 3073572 [TBL] [Abstract][Full Text] [Related]
31. [Changes in the hemodynamic indices of hypertension patients]. Shvedenko LA; Parashchak AP; Iurkevich ST; Neporadnyĭ MD; Bigar' PV Vrach Delo; 1983 Apr; (4):76-9. PubMed ID: 6868543 [No Abstract] [Full Text] [Related]
32. [Hemodynamic basis of the medical treatment of arterial hypertension]. Milliez P; Safar M Bull Acad Natl Med; 1971 Jan; 155(3):66-74. PubMed ID: 4936689 [No Abstract] [Full Text] [Related]
34. [Microcirculation and central hemodynamics of hypertension patients during long-term hypotensive therapy]. Tsikulin AE Ter Arkh; 1984; 56(9):30-3. PubMed ID: 6515544 [TBL] [Abstract][Full Text] [Related]
35. [Clinical effect of prostenon in patients with resistant arterial hypertension and target organs complications]. Zeĭnalov FM Klin Med (Mosk); 1999; 77(4):13-5. PubMed ID: 10356909 [No Abstract] [Full Text] [Related]
36. [Use of crystepin in combination with obsidan in patients with diabetes mellitus with arterial hypertension]. Leviashvili BI Klin Med (Mosk); 1989 Mar; 67(3):34-7. PubMed ID: 2747151 [TBL] [Abstract][Full Text] [Related]